Treatment of Hyperprolactinemia in Amenorrhea Caused by a Prolactin-Secreting Pituitary Microadenoma

Clinical Scenario

This protocol addresses hyperprolactinemia in female patients presenting with amenorrhea attributable to a prolactin-secreting pituitary microadenoma. The combination of elevated prolactin and menstrual disruption from a microadenoma defines this specific sub-population.

Treatment Approach

Current evidence supports a pharmacological approach targeting the underlying hormonal abnormality. The general strategy involves a choice between two classes of agent — the full treatment selection, criteria, and sequencing are detailed in the complete protocol.

Complete dosing, agent selection criteria, and monitoring parameters are available in the full structured regimen.